ScholarWorks@Korea University College of Medicine: Kang, Kyung Ho

Detailed Information

Kang, Kyung Ho (강경호)

Guro Hospital (Department of Pulmonary, Allergy, and Critical Care Medicine, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Asthma:10||COPD:7||asthma:5||tuberculosis:5||epidermal growth factor receptor:4||Acute lung injury:4||exacerbation:4||Polymorphism:4||mucus hypersecretion:3||epidemiology:3||Korea:3||neurogenic inflammation:3||Prognosis:3||smoking:3||Lung cancer:3||Pulmonary fibrosis:3||lung cancer:3||Nonsmall cell lung cancer:3||EGFR:3||Lung:3||pleural effusion:3||Reactive oxygen species:3||proteomics:3||Biomarker:3||Oxidative stress:2||Chronic obstructive pulmonary disease:2||Lung neoplasms:2||PTEN:2||tobacco smoke:2||Cryotherapy:2||Paraquat:2||HRCT:2||vasculitis:2||Pep1 peptide:2||nitric oxide synthase:2||Relapsing polychondritis:2||FK224:2||airway:2||ACO:2||천식:2||Dactylitis:2||anaphylaxis:2||Sarcoidosis:2||Pneumonia:2||Chemotherapy:2||Small cell lung cancer:2||Bronchial asthma:2||Smoking:2||Endothelin1:2||Pranlukast:2||inflammation:2||Lipopolysaccharide:2||Eosinophilic bronchitis:2||IgE:2||Procalcitonin:2||regulatory T cell:2||Chronic cough:2||Inflammation:2||Promoter:2||lipopolysaccharide:2||Gemcitabine:2||combined pulmonary fibrosis and emphysema:2||Interleukin4:2||Lung disease:2||Epidermal growth factor receptor:2||Pulmonary hypertension:2||Critical care:1||Cromolyn:1||Cyclooxygenase2 (COX2):1||Cyclophosphamide:1||Dactylitis.:1||Dermatomyositis:1||Diagnosis:1||Diffuse alveolar hemorrhage:1||Diseases progression:1||Drug therapy:1||EDRF:1||EGF receptor:1||ERCC1:1||Elastic liposomes:1||Elevated pulmonary capillary wedge pressure:1||Embolism:1||Emergency Room:1||Endobronchial mass:1||Eosinophilia:1||Eotaxin:1||Ethyl pyruvate:1||Exerciseinduced asthma:1||Extramedullary plasmacytoma:1||Factor XIII:1||Fat embolism:1||Fibrosing mediastinitis:1||Firstline chemotherapy:1||Fluorouracil:1||Foxp3:1||Fungi:1||Furosemide:1||GAP score:1||Gastroesophageal reflux:1||Gefitinib:1||Goblet cell hyperplasia:1||Golytely:1||Guideline:1||HFRS:1||Health surveys:1||Heat shock protein:1||Hemoptysis:1||Heparin:1||High dose rate brachytherapy:1||Hydrogen sulfide:1||Hypertension:1||Hyponatremia:1||Ikappa B kinase inhibitor:1||IDO:1||IL13:1||Inappropriate ADH syndrome:1||Inhaled corticosteroids:1||Intermittent positive pressure ventilation:1||Interstitial:1||Interstitial lung disease:1||Irinotecan:1||Kimura disease:1||LNMMA:1||Larginine:1||Laser therapy:1||Leucovorin:1||Leukotriene:1||Leukotriene antagonist:1||Leukotriene receptor antagonist:1||Limbic encephalitis:1||Limitedstage:1||Lipid:1||Lipopolysaccharides:1||Liposome:1||Long acting β2agonist:1||Longterm home oxygen therapy:1||Lung adenocarcinoma:1||Lung cancer Radiotherapy:1||Lung diseases:1||Lung imaging fluorescence endoscopic device:1||Lymphocyte:1||Lymphocytic Interstitial Pneumonitis (LIP):1||MMP9:1||Mediastinal neoplasm:1||Mediastinum:1||Methylprednisolone:1||Mildtomoderate asthma:1||Moxifloxacin:1||Mucus hypersecretion:1||Mulberry:1||Muscle relaxant:1||NC/Nga mice:1||NRAMP1 genetic polymorphism:1||Neurogenic inflamination:1||Neutrophilic inflammation:1||Nonsmall cell lung carcinoma:1||Nonsmallcell lung carcinoma:1||Nonsmall cell lung cancer:1||Not available:1||Nramp1 protein:1||Nuclear factor kappa B:1||Occupational lung disease:1||Oligodeoxynucleotides:1||Osteoporosis:1||Oxaliplatin:1||PGE(2):1||PPARgamma:1||Paraneoplastic syndromes:1||Parapneumonic effusion:1||Passive smoking:1||Perfusion:1||Peripheral Tcell lymphoma:1||Phase II study:1||Plasma extravasation:1||Plasmacytoma:1||Platinum:1||Pleural effusion:1||Poly (ADPribose) polymerase1:1||Poly (ADPribose) polymerase1 inhibitor:1||Portal hypertension:1||Predictive marker:1||Pregnancy:1||Pressure:1||Primary Pulmonary Hypertension:1||Primary biliary cirrhosis:1||Prognostic factor:1||Programmed death ligand 1:1||Propylthiouracil:1||Proteomic analysis:1||Pulmonary Disease:1||Pulmonary adenocarcinoma:1||Pulmonary artery aneurysm:1||Pulmonary edema:1||Pulmonary nodules:1||Pulmonary plasmacytoma:1||Pulmonary reaction:1||Pulmonary sarcomatoid carcinoma:1||Pulmonary veno  occlusive disease:1||Pulmonary venoocclusive disease:1||Quercetin:1||Randomized clinical trial:1||Receptor:1||Reimbursement:1||Relation:1||Respiration, Artificial:1||Respiratory Distress Syndrome, Adult:1||Respiratory bronchiolitis:1||Respiratory function tests:1||Seoul virus:1||Serum:1||Skeletalrelated event:1||Small cell lung carcinoma:1||Specific model airway resistance:1||Squalene:1||Start of any treatment until the end of radiotherapy:1||Superior vena cava syndrome:1||Surgery:1||Syndrome:1||Tlyrnphocytes:1||TGFβ1.:1||TNF alpha:1||TRALI:1||TXNL2 protein:1||Taxifolin glycoside:1||Thymidylate synthase:1||Tracheal papillomatosis:1||Tracheobronchus:1||Tracheobronchus.:1||Transglutaminase 2:1||Trauma:1||Treatment outcome:1||Tuberculous pleural effusion:1||Tuberculous pneumonia:1||Upper airway obstruction:1||Urokinase:1||Vascular endothelial growth factor:1||VentilatorInduced Lung Injury:1||Ventilatorassociated event:1||Ventilatorassociated pneumonia:1||Ventilatorinduced lung injury:1||Vinorelbine:1||Wild type:1||acute exacerbation:1||adipose stem cell:1||air pollution:1||air quality index:1||airway hyperresponsivenesss:1||airway inflammation:1||airway obstruction:1||allergen:1||amiodarone:1||apolipoprotein M:1||aspiration pneumonia:1||asthmalike symptoms:1||basophil activation:1||biomarker:1||bleomycin:1||bonchiolitis obliterans:1||bronchial hyperresponsiveness:1||bronchial leiomyosarcoma:1||bronchial rupture:1||bronchioloalveolar cell carcinoma:1||bronchoscopy:1||cardiovascular diseases:1||cavitary lesion:1||cell therapy:1||cellpenetrating peptide:1||chemotherapy:1||chronic obstructive:1||cisplatin:1||classical asthma:1||club cell secretory protein16:1||comorbidity:1||concurrent chemoradiation therapy:1||correlates:1||cough:1||coughvariant asthma:1||coughvarient asthma:1||ct Mri Etc:1||cyclooxygenase:1||cytotoxic Tlymphocyte antigen4 polymorphism:1||delayed repair:1||deterioration:1||diffuse panbronchiolitis:1||drug allergy:1||elderly:1||embolization:1||eosinophilic bronchitis:1||epidermal growth factor:1||expectoration:1||food allergy:1||functional upper airway obstruction:1||fungating mass:1||gefitinib:1||glucose tolerance:1||goblet cell hyperplasia:1||goblet cell metaplasia:1||haemangioma:1||haptoglobin:1||hepatocellular carcinoma:1||histamine release:1||histological type:1||human:1||hypoxia:1||imaging:1||immune tolerance:1||in situ:1||indoleamine2:1||inhaled corticosteroid:1||insulin resistance:1||interleukin (IL)6:1||interleukin10:1||interleukin27:1||intermittent positive pressure ventilation:1||intracellular delivery:1||irinotecan:1||leiomyosarcoma:1||levodropropizine:1||limited stage:1||lung:1||lung imaging fluorescence endoscopic device:1||lung injury:1||lymphocytic bronchitis:1||macromolecule:1||malignant fibrous histiocytoma:1||malignant lymphoma:1||malignant mesothelioma:1||manifestation:1||matrix metalloproteinase 13:1||mechanical ventilators:1||mediastinum:1||metabolic syndrome:1||metabolomics:1||metalloproteinase inhibitor:1||mortality:1||mouse:1||mucin:1||multiple sites:1||neoplasm staging:1||neutrophil:1||nonsmall cell lung carcinoma:1||nonsmallcell lung carcinoma:1||nonpenetrating trauma:1||obstructive sleep apnoea:1||oral provocation test:1||outcome:1||ovalbumin:1||pancreatic pseudocyst:1||pancreaticopleural fistula:1||paraoxonase1:1||particulate matter:1||phosphatase and tensin homolog deleted on chromosome 10:1||plasma extravasation:1||pleura:1||pleural:1||polymerase chain reaction:1||polymorphism:1||predictors:1||prevalence:1||prognostic factors:1||prostaglandin 8epiPGF2alpha:1||pulmonary disease:1||pulmonary embolism:1||pulmonary fibrosis:1||pulmonary hypertension:1||pulmonary vasoconstriction:1||pulmonary venoocclusive disease:1||rebamipide:1||rhabdomyosarcoma:1||rheumatoid arthritis:1||rosiglitazone:1||rosigtitazone:1||sardoidosis:1||scleroderma:1||secondline treatment:1||serum:1||single nucleotide polymorphism:1||sleep apnea:1||sleepdisordered breathing:1||smallcell lung cancer:1||solitary pulmonary nodule:1||sputum:1||statin:1||substanceP reactive nerves:1||systemic sclerosis:1||therapeutic modality:1||toxicity:1||transforming growth factorbeta:1||tuberculous pleural effusion:1||urinary Lhistidine:1||urokinase:1||vocal cord dysfunction:1||β2 Adrenergic receptor:1||β2 교감신경 수용체 다형성:1||기관지 수축반응:1||만성 기침:1||방사선 화학 동시요법:1||백서의 폐섬유화증:1||비발효성 그람음성 간균:1||비소세포폐암:1||스테로이드:1||임신:1||저산소성 폐질환:1||점액성 평활근육종:1||테스트:1||폐혈전색전증:1||0:1||한냉글로불린혈증 환자:1||02170217:1||1:1||1st line therapy:1||3dioxygenase:1||ACE gene polymorphism:1||ACE inhibitor:1||ANCA:1||ARDS:1||Abdomen:1||Actinomycosis:1||Actinomyocosis:1||Acute Lung Injury:1||Acute exacerbation:1||Acute exacerbation of chronic bronchitis:1||Acute interstitial pneumonia:1||Adult:1||Airway hyperresponsiveness:1||Airway inflammation:1||Anaplastic large cell lymphoma:1||Animal asthma model:1||Animal body plethysmography:1||Apoptosis:1||Atopic dermatitis:1||Atopy:1||BAL:1||Bacterial:1||Beta2 adrenergic receptor:1||BiPAP (bilevel positive airway pressure):1||BiPAP(Bilevel positive airway pressure):1||Biologic markers:1||Biomarkers:1||Blood transfusion:1||Bone Mineral Density:1||Bone metastases:1||Bosentan:1||Bronchial disease:1||Bronchial mucosa:1||Bronchiectasis:1||Bronchoalveolar lavage fluid:1||Bronchogenic Carcinoma:1||Bronchoscopy:1||Budesonide:1||CerbB2:1||Creactive protein:1||CD4+:1||CD8+:1||COX2:1||CPG 올리고 뉴클레오티드:1||CT:1||Carboplatin:1||Carcinoid tumor:1||Castleman's disease:1||Central airway obstruction:1||Chemical pneumonitis:1||Chemoradiotherapy:1||Chronic Obstructive:1||Chronic bronchitis:1||Chronic respiratory insufficiency:1||Cisplatin:1||Clarithromycin:1||Coccidioidomycosis:1||Compartment syndrome:1||Congenital brnochoesophageal fistula:1||Cough:1||Cough variant asthma:1||

STATISTICS: Total View :12,661,155; Today View :7,434

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE